1. Home
  2. ALG vs RARE Comparison

ALG vs RARE Comparison

Compare ALG & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alamo Group Inc.

ALG

Alamo Group Inc.

HOLD

Current Price

$150.12

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo Ultragenyx Pharmaceutical Inc.

RARE

Ultragenyx Pharmaceutical Inc.

HOLD

Current Price

$22.41

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALG
RARE
Founded
1955
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
ALG
RARE
Price
$150.12
$22.41
Analyst Decision
Buy
Strong Buy
Analyst Count
3
20
Target Price
$225.00
$59.10
AVG Volume (30 Days)
196.8K
1.5M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
7.31
EPS
2.41
N/A
Revenue
$1,603,715,000.00
$673,000,000.00
Revenue This Year
$5.26
$13.12
Revenue Next Year
$3.97
$37.80
P/E Ratio
$63.39
N/A
Revenue Growth
N/A
20.13
52 Week Low
$145.76
$18.29
52 Week High
$233.29
$40.17

Technical Indicators

Market Signals
Indicator
ALG
RARE
Relative Strength Index (RSI) 38.55 38.01
Support Level $145.76 $20.11
Resistance Level $156.54 $23.44
Average True Range (ATR) 4.78 1.09
MACD 0.50 -0.32
Stochastic Oscillator 37.38 13.30

Price Performance

Historical Comparison
ALG
RARE

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial, and agricultural use. Its products include agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck-mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, snow removal equipment, etc. The company's reportable segments are Vegetation Management, which generates the maximum revenue, and Industrial Equipment. Geographically, the company generates maximum revenue from the United States, followed by Canada, France, the UK, Brazil, the Netherlands, and other regions.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Share on Social Networks: